Literature DB >> 17008892

A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib.

F X Gruber, H Hjorth-Hansen, I Mikkola, L Stenke, T Johansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17008892     DOI： 10.1038/sj.leu.2404400

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  12 in total

Review 1.  BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors.

Authors:  Wanlong Ma; Hagop Kantarjian; Chen-Hsiung Yeh; Zhong J Zhang; Jorge Cortes; Maher Albitar
Journal:  Acta Haematol       Date:  2009-03-31       Impact factor: 2.195

2.  Detection of twelve nucleotides insertion in the BCR-ABL kinase domain in an imatinib-resistant but dasatinib-sensitive patient with bi-phenotypic acute leukemia.

Authors:  Sandrine Hayette; Kaddour Chabane; Andrei Tchirkov; Marc G Berger; Franck E Nicolini; Olivier Tournilhac
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

3.  Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia.

Authors:  Nóra Meggyesi; Lajos Kalmár; Sándor Fekete; Tamás Masszi; Attila Tordai; Hajnalka Andrikovics
Journal:  Med Oncol       Date:  2011-10-30       Impact factor: 3.064

4.  BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?

Authors:  Franz X Gruber; Tuija Lundán; Rasmus Goll; Aleksandra Silye; Ingvild Mikkola; Ole Petter Rekvig; Sakari Knuutila; Kari Remes; Tobias Gedde-Dahl; Kimmo Porkka; Henrik Hjorth-Hansen
Journal:  Med Oncol       Date:  2011-01-08       Impact factor: 3.064

5.  Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation.

Authors:  Daniel N Egan; Lan Beppu; Jerald P Radich
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-06       Impact factor: 5.742

6.  Effector caspases and leukemia.

Authors:  Ying Lu; Guo-Qiang Chen
Journal:  Int J Cell Biol       Date:  2011-04-14

7.  Alternative splicing in oncogenic kinases: from physiological functions to cancer.

Authors:  Sabine Druillennec; Coralie Dorard; Alain Eychène
Journal:  J Nucleic Acids       Date:  2011-10-05

8.  Rapid identification of compound mutations in patients with Philadelphia-positive leukaemias by long-range next generation sequencing.

Authors:  R Kastner; A Zopf; S Preuner; J Pröll; N Niklas; P Foskett; P Valent; T Lion; C Gabriel
Journal:  Eur J Cancer       Date:  2013-12-20       Impact factor: 9.162

9.  ExonMiner: Web service for analysis of GeneChip Exon array data.

Authors:  Kazuyuki Numata; Ryo Yoshida; Masao Nagasaki; Ayumu Saito; Seiya Imoto; Satoru Miyano
Journal:  BMC Bioinformatics       Date:  2008-11-26       Impact factor: 3.169

10.  Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia.

Authors:  Pavinder Kaur; Niklas Feldhahn; Bin Zhang; Daniel Trageser; Markus Müschen; Veerle Pertz; John Groffen; Nora Heisterkamp
Journal:  Mol Cancer       Date:  2007-10-25       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.